Plavix Makers Fight For Exclusivity

Law360, New York (January 22, 2007, 12:00 AM EST) -- Sanofi-Aventis and Bristol-Myers Squibb Co. begged the court to uphold their patent for blood thinning medication Plavix, as a trial over the blockbuster drug got underway Monday.

The trial pits the brand name drug titans against Canada-based generic maker Apotex Inc., which launched an “at-risk” generic version of Plavix on Aug. 8 following the failure of a settlement deal with France-based Sanofi and its U.S. partner Bristol-Myers.

The settlement would have delayed a generic version of the drug from hitting the market until 2011.

In opening...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.